Universal Ibogaine Statistics

Total Valuation

TSXV:IBO has a market cap or net worth of CAD 6.17 million. The enterprise value is 8.62 million.

Market Cap	6.17M
Enterprise Value	8.62M

Important Dates

The last earnings date was Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	n/a

Share Statistics

TSXV:IBO has 308.61 million shares outstanding. The number of shares has increased by 38.51% in one year.

Current Share Class	308.61M
Shares Outstanding	308.61M
Shares Change (YoY)	+38.51%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	9.23%
Owned by Institutions (%)	n/a
Float	280.11M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.00
PB Ratio	22.68
P/TBV Ratio	22.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.84
EV / Sales	4.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.99

Financial Position

The company has a current ratio of 0.39, with a Debt / Equity ratio of 9.45.

Current Ratio	0.39
Quick Ratio	0.37
Debt / Equity	9.45
Debt / EBITDA	n/a
Debt / FCF	-3.88
Interest Coverage	-4.50

Financial Efficiency

Return on equity (ROE) is -161.37% and return on invested capital (ROIC) is -12.30%.

Return on Equity (ROE)	-161.37%
Return on Assets (ROA)	-9.46%
Return on Invested Capital (ROIC)	-12.30%
Return on Capital Employed (ROCE)	-35.38%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.44
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +300.00% in the last 52 weeks. The beta is 6.56, so TSXV:IBO's price volatility has been higher than the market average.

Beta (5Y)	6.56
52-Week Price Change	+300.00%
50-Day Moving Average	0.02
200-Day Moving Average	0.02
Relative Strength Index (RSI)	75.81
Average Volume (20 Days)	90,577

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSXV:IBO had revenue of CAD 2.06 million and -1.48 million in losses. Loss per share was -0.00.

Revenue	2.06M
Gross Profit	356,649
Operating Income	-705,732
Pretax Income	-1.48M
Net Income	-1.48M
EBITDA	-358,281
EBIT	-705,732
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 127,746 in cash and 2.57 million in debt, giving a net cash position of -2.44 million or -0.01 per share.

Cash & Cash Equivalents	127,746
Total Debt	2.57M
Net Cash	-2.44M
Net Cash Per Share	-0.01
Equity (Book Value)	272,174
Book Value Per Share	0.00
Working Capital	-1.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -642,802 and capital expenditures -20,695, giving a free cash flow of -663,497.

Operating Cash Flow	-642,802
Capital Expenditures	-20,695
Free Cash Flow	-663,497
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 17.31%, with operating and profit margins of -34.25% and -71.66%.

Gross Margin	17.31%
Operating Margin	-34.25%
Pretax Margin	-71.66%
Profit Margin	-71.66%
EBITDA Margin	-17.39%
EBIT Margin	-34.25%
FCF Margin	n/a

Dividends & Yields

TSXV:IBO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-38.51%
Shareholder Yield	n/a
Earnings Yield	-23.92%
FCF Yield	-10.75%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3